logo
The #1 Mistake People Make When Cutting Back on Calories, According to Dietitians

The #1 Mistake People Make When Cutting Back on Calories, According to Dietitians

Yahoo5 days ago
Reviewed by Dietitian Kelly Plowe, M.S., RDKey Points
Fiber often becomes a shortfall nutrient when eating too few calories in an attempt to lose weight.
Focusing on protein and eating a very low-calorie diet are reasons why we don't get enough fiber.
Eating a high-fiber breakfast and a variety of foods can help you meet your daily fiber quota.Many weight loss diets share a commonality: they restrict calories. After all, at the most basic level, your weight status is an equation of calories in, calories out. Research suggests that maintaining a calorie deficit (i.e., consuming fewer calories than you expend each day) is a primary factor in achieving weight loss. 'Calorie restriction can be very effective for short-term weight loss,' says weight loss dietitian Melissa Mitri, M.S., RD. However, Mitri emphasizes that other factors, like the types of food you eat, a consistent exercise routine, and effective stress management strategies, are also crucial for maintaining long-term weight loss.
Effective as it may be, maintaining a calorie deficit can come with some common mistakes. The one Mitri says she sees most often: not consuming enough fiber. Neglecting this critical nutrient can do a surprising amount of harm to your weight loss efforts, not to mention derailing your digestion and downgrading your overall health. Here's why dietitians say we often fall short of fiber when on a calorie-restricted diet and how you can ensure you're getting enough.
Why Fiber Falls By the Wayside When Trying to Lose Weight
Fiber Isn't Exciting
Let's be honest, in terms of popularity, fiber doesn't hold a candle to other, glitzier nutrients like protein or dietary supplements. 'One of the reasons people don't get enough fiber is because they simply aren't focused on it,' says weight loss dietitian Lainey Younkin, M.S., RD, LDN. 'It doesn't get as much attention as protein on social media.' Fiber's longtime association with unsexy digestive habits could be to blame for its lack of pizzazz as a weight loss aid.
That said, fiber is a key nutrient for weight loss. Eating more of it is strongly associated with successful weight management, so it may be time to shift to a more balanced approach, prioritizing fiber along with other nutrients. Younkin says reading labels is a great place to start. 'Look at the dietary fiber [on Nutrition Facts labels] to see how much is in various foods that you buy.'
The Focus Is On Protein
It's no surprise that protein is all the rage at the moment. According to a 2025 survey by the International Food Information Council, 70% of Americans reported trying to consume more protein, a significant increase from 67% in 2023 and 59% in 2022. Additionally, high-protein diets have ranked as the most-followed eating pattern for the third consecutive year.
Protein is well and good, but it's not the only superstar nutrient for weight loss. 'There is so much emphasis on protein for weight loss from the media and influencers, which leads many to believe this is the only thing that matters,' Mitri says. 'While protein is essential for health and certainly is one key nutrient for weight loss, fiber is just as essential to enhance fullness and provide volume on a reduced-calorie diet.' Not sure how much protein you need? Check out our protein calculator as a guide.
Overestimating Fiber Intake
If you eat a balanced diet, it's easy to believe your fiber needs are taken care of. But that's not necessarily the case. '[People often] assume that they're getting enough from eating more fruits and vegetables, and while fruits and vegetables have fiber, you have to eat a lot of them to hit your daily fiber goal of 25-38 grams per day,' Younkin says.
To do so, Younkin suggests varying your plate with whole grains, beans and legumes. And if you're concerned about overdoing it on carbs, fear not! 'I often find that clients are scared of carbs, but there's no need to avoid them,' says Younkin. 'It's about choosing high-fiber carbohydrates and limiting refined carbohydrates. This will help you get more fiber, stay full longer and aid weight loss.'
Eating Too Few Calories
Sure, calorie restriction can be effective for weight loss, but taking it too far can mean overrestricting on fiber as well. 'A lot of my clients often think the fewer calories they eat, the better, especially if they've followed very low-calorie or overly restrictive diets in the past,' Mitri says. On an extremely calorie-controlled diet, however, it can be hard to reach the recommended amounts of fiber. Each gram of fiber contains 4 calories. At the recommended 25 grams for women and 38 grams for men, this equates to just 100 and 152 calories, respectively, from fiber each day.
How to Eat Enough Fiber When Trying to Cut Calories
When pursuing weight loss, stick to these dietitian-recommended strategies to keep fiber high and calories low.
Prioritize protein fiber. Both of these nutrients are important for staying full. 'When planning your meals, ensure you have one to two quality sources of both protein and fiber, such as tuna or chicken for protein and leafy greens for fiber, which will help keep you full and thus make it easier to stick to a reduced-calorie diet,' Mitri advises.
Keep variety in mind. You'll find fiber in all sorts of foods, so don't limit yourself to a mere handful of fruits and veggies. Whole grains, beans, nuts and seeds are other high-fiber choices.
Incorporate favorite foods. If you're not enjoying your diet, you're less likely to stick with it. Mitri encourages keeping favorite foods on rotation, even when striving for a calorie deficit. Consider which high-fiber foods you genuinely like in your meals and snacks.
Try a bigger, high-fiber breakfast. Younkin says the right breakfast can set you up for calorie-deficient success. 'Instead of trying to eat less, eat enough of the right nutrients to keep you full and satisfied (protein, fiber and healthy fat), so you don't raid the pantry later and end up in a calorie surplus.' Try adding high-fiber breakfast choices like oatmeal, bran cereal or a berry yogurt parfait.
Our Expert Take
On a low-calorie diet, fiber is your friend. While it might not seem like the most impactful nutrient, it plays a major role in promoting satiation, curbing cravings and regulating digestion—all of which factor into the success of a weight loss program. As you dial down your calories, don't fall prey to the mistake of neglecting fiber intake. High-fiber fruits, vegetables, whole grains, beans, nuts and seeds all deserve a place on a weight loss-friendly plate.
Read the original article on EATINGWELL
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial
United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial

Yahoo

time39 minutes ago

  • Yahoo

United Therapeutics Corporation (UTHR) Launches First UKidney Human Trial

We recently compiled a list of United Therapeutics Corporation stands sixth on our list and has launched the first UKidney human trial. United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company focused on treating rare, life-threatening diseases such as pulmonary arterial hypertension (PAH) and advancing technologies to address the shortage of transplantable organs. As the first major biotech to become a Public Benefit Corporation, it combines innovation with social impact, especially in organ transplantation. In 2025, the company launched the first human clinical trial of UKidney, a gene-edited pig kidney, in patients with end-stage renal disease (ESRD). The FDA cleared the IND in February, and the first transplant is expected by mid-year. The UKidney features ten genetic modifications to improve human compatibility. The initial trial includes six patients, with plans to expand to 50. United Therapeutics Corporation (NASDAQ:UTHR), often cited among the most undervalued stocks in the biotech industry, is investing $100 million in expanding its Silver Spring, Maryland, organ production campus. This facility will drive large-scale manufacturing of bioengineered organs, leveraging work by its subsidiary, Revivicor, which has already achieved successful pig-to-human organ transplants. In parallel, the business continues advancing therapies for PAH and pulmonary hypertension. It completed enrollment in its TETON-2 trial (inhaled treprostinil for idiopathic pulmonary fibrosis) with results expected later in 2025, and is progressing with other investigational drugs like rilaprag. A biotechnologist in a lab coat discussing a therapeutic antibody with a colleague. By pioneering xenotransplantation and expanding infrastructure, United Therapeutics Corporation (NASDAQ:UTHR) aims to revolutionize organ transplantation and significantly reduce the gap between organ supply and demand. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten

California doctor sued for ‘wrongful death' after shipping abortion drugs interstate in legal first
California doctor sued for ‘wrongful death' after shipping abortion drugs interstate in legal first

Yahoo

time39 minutes ago

  • Yahoo

California doctor sued for ‘wrongful death' after shipping abortion drugs interstate in legal first

A Texas man is suing a doctor in California he claims mailed his girlfriend pills to end her pregnancy - in what may be a legal first - and a test of new state abortion laws. Jerry Rodriguez filed a wrongful death lawsuit against Remy Coeytaux, after the doctor sent the abortion-inducing drugs across state lines in order to 'murder his unborn son,' Rodriguez claimed. It appears to be the first time an interstate lawsuit for wrongful death over an abortion has been filed, according to The Washington Post. In Texas, a person who assists a pregnant woman in obtaining a self-managed abortion commits the crime of murder and can be sued for wrongful death, the lawsuit, filed in Texas federal court and obtained by The Independent, states. The woman herself cannot be prosecuted. The suit adds it is also a state jail felony for anyone other than a Texas-licensed physician to provide an abortion-inducing drug for the purpose of inducing an abortion. 'In violation of these and many other laws, defendant Remy Coeytaux mailed abortion-inducing drugs into Texas that were used to murder Jerry Rodriguez's unborn child,' the complaint reads. Rodriguez is suing Coeytaux for $75,000 over what he claims is wrongful death. He's also seeking an injunction to stop the doctor from distributing abortion-inducing drugs in violation of state or federal law. The injunction, the suit states, is being sought 'on behalf of a class of all current and future fathers of unborn children in the United States.' But such state legislation clashes with that of California, which retains a so-called 'Shield Law' to protect medical professionals such as Coeytaux. The law provides that 'California will not deliver a person accused or charged with committing a crime related to abortion/gender-affirming care over to law enforcement officials.' This includes situations where a California-licensed pharmacist dispenses an abortion-inducing drug mifepristone to a patient in a state with abortion-restrictive laws. According to Rodriguez's suit, he began dating his girlfriend in June 2024, while she was separated from her husband, but not yet divorced. The Independent has chosen not to name the woman, due to privacy reasons and because she is not a defendant in the lawsuit. The suit alleges that the woman's husband, Adam Garza, twice ordered the abortion medication from Coeytaux after she became pregnant by Rodriguez 'with the intent of using them to murder Mr. Rodriguez's unborn child,' and 'pressured her' to take the pills. A Venmo receipt confirming Garza's purchase of the drugs from Coeytaux was included in the lawsuit, with a reference of ''Aed axes' – allegedly a homonym for 'Aid Access,' an organization that ships abortion-inducing drugs into jurisdictions where abortion is not legal. 'Defendant Coeytaux caused the death of Mr. Rodriguez's unborn child through his wrongful acts,' the lawsuit states. 'Although [the woman] cannot be charged with murder for her role in killing her unborn child, her immunity does not shield Coeytaux from liability for aiding or abetting or directly participating in the murder.' 'Mr. Rodriguez seeks this injunction on behalf of a class of all current and future fathers of unborn children in the United States.' The Independent has reached out to Dr Remy Coeytaux for comment on the lawsuit.

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment
Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment

Yahoo

time41 minutes ago

  • Yahoo

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment

We recently compiled a list of Vertex Pharmaceuticals Incorporated stands second on our list and has recently launched the first non opioid acute pain treatment. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), a global biotech firm based in Boston, is known for developing innovative treatments for serious diseases like cystic fibrosis, sickle cell disease, and beta thalassemia. The company is recognized for its strong pipeline targeting unmet medical needs. In July 2025, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) launched JOURNAVX (suzetrigine), a first-in-class, non-opioid treatment for moderate-to-severe acute pain. JOURNAVX, an oral NaV1.8 pain signal inhibitor, was named a 2025 Breakthroughs Innovation Celebration winner by Premier, Inc. It represents the first new class of pain medicine in decades and offers a safer alternative to opioids by directly targeting pain pathways without addiction risks. This launch marks a major advancement in pain management, aligning with public health efforts to reduce opioid use. JOURNAVX is especially relevant for acute pain scenarios such as post-surgical recovery and injury care. A closeup of pills in a pharmacy, representing the high quality medications of the company. Beyond acute pain, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) continues to expand its reach. Its next-gen cystic fibrosis therapy, ALYFTREK, received approval from the European Commission in July 2025, strengthening its global leadership in this area. The company is also advancing gene-editing therapies like CASGEVY for sickle cell and beta thalassemia, and is developing treatments for kidney disease, type 1 diabetes, and rare genetic disorders. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store